Buscar por Autor Sánchez del Campo Ferrer, Luis
Mostrando resultados 1 a 17 de 17
| Vista previa | Fecha de publicación | Fecha de Creación | Título |
| 31-ago-2005 | 2005 | Muscular dystrophy by merosin deficiency decreases acetylcholinesterase activity in thymus of Lama2dy mice |
 | 2007 | - | Effects of folate cycle disruption by the green tea polyphenol epigallocatechin-3-gallate |
 | 10-abr-2008 | - | Synthesis and Biological Activity of a 3,4,5-Trimethoxybenzoyl Ester Analogue of Epicatechin-3-gallate |
 | 15-nov-2008 | - | Targeting the methionine cycle for melanoma therapy with 3-O-(3,4,5-trimethoxybenzoyl)-(-)-epicatechin |
 | 2009 | - | Diseño, síntesis y actividad antitumoral de un inhibidor de la dihidrofolato reductasa, derivado de las catequinas del té, para el tratamiento del melanoma / Luis Sánchez del Campo Ferrer; director José Neptuno Rodríguez López. |
 | 10-ene-2009 | - | The critical role of alpha-folate receptor in the resistance of melanoma to methotrexate |
 | 9-abr-2009 | - | Melanoma Activation of 3-O-(3,4,5-Trimethoxybenzoyl)-(-)-Epicatechin to a Potent Irreversible Inhibitor of Dihydrofolate Reductase |
 | 18-dic-2009 | - | Binding of Natural and Synthetic Polyphenols to Human Dihydrofolate Reductase |
 | 1-jun-2010 | - | Mechanism of Dihydrofolate Reductase Downregulation in Melanoma by 3-O-(3,4,5-Trimethoxybenzoyl)-(-)-Epicatechin |
 | 7-mar-2011 | - | Comparison of a Pair of Synthetic Tea-Catechin-Derived Epimers: Synthesis, Antifolate Activity, and Tyrosinase-Mediated Activation in Melanoma |
 | 10-dic-2015 | 4-dic-2015 | Bases moleculares de la resistencia del melanoma a los antifolatos: diseño de nuevas estrategias terapéuticas |
 | 6-ago-2020 | - | PRMT1-dependent methylation of BRCA1 contributes to the epigenetic defense of breast cancer cells against ionizing radiation |
 | 31-dic-2020 | - | Acriflavine, a Potent Inhibitor of HIF-1α, Disturbs Glucose Metabolism and Suppresses ATF4-Protective Pathways in Melanoma under Non-Hypoxic Conditions |
 | 31-mar-2021 | - | MITF induces escape from innate immunity in melanoma |
 | 1-jul-2021 | 5-jun-2019 | Regulación de ADAM10 mediada por MITF en la respuesta inmune contra el melanoma |
 | 23-nov-2023 | - | Targeting protein methylation in pancreatic cancer cells results in KRAS signaling imbalance and inhibition of autophagy |
 | 5-feb-2024 | 2-feb-2024 | Reprogramación metabólica e inmunogénica para mejorar la respuesta antitumoral en melanoma y cáncer de páncreas |
